Talimogene laherparepvec - Benefit assessment according to §35a Social Code Book V

Report documents

1. Extract of dossier assessment

   Talimogene laherparepvec - Benefit assessment according to §35a Social Code Book V

   published on

   15.09.2016

   Document type

   PDF document, 107 kB, EN, not accessible

   Download file : Extract of dossier assessment (PDF document, 107 kB, EN, not accessible)
2. Dossier assessment

   Talimogene laherparepvec - Benefit assessment according to §35a Social Code Book V

   published on

   15.09.2016

   Document type

   PDF document, 269 kB, DE, not accessible

   Download file : Dossier assessment (PDF document, 269 kB, DE, not accessible)

Press releases

Additional information

Project details

Project no.

A16-37

Commission

Commission awarded on 15.06.2016 by the Federal Joint Committee (GBA).

Report type

Dossier assessment

Status

Commission completed

Department/Division

Drug Assessment

Topic

Cancer

Note

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.